← Evidence map

ArticlePharmaceutics2022

Bio-Responsive Carriers for Controlled Delivery of Doxorubicin to Cancer Cells.

Gheorghe Fundueanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35456699